Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091687 · ClinicalTrials.gov registry record
Longitudinal Outcomes in Pediatric rTMS and CIT
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 19
- Enrollment target
NCT02091687: Completed study, sponsored by University of Minnesota.
NCT02091687 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02091687 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Track behavioral and qualitative longitudinal outcomes in children with hemiparesis who previously participated in a randomized, controlled trial (RCT) of intensive therapy combined with repetitive Transcranial Magnetic Stimulation (rTMS)
Primary Outcome
This checklist assists in monitoring children who have had TMS for side effects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-02-01 |
What the finished NCT02091687 record still lists
NCT02091687 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02091687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02091687 about?
NCT02091687 is a clinical study titled "Longitudinal Outcomes in Pediatric rTMS and CIT". Track behavioral and qualitative longitudinal outcomes in children with hemiparesis who previously participated in a randomized, controlled trial (RCT) of intensive therapy combined with repetitive Transcranial Magnetic Stimulation (rTMS)
What is the current status of trial NCT02091687?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2014-04. Estimated completion is 2017-02-01.
Who is sponsoring clinical trial NCT02091687?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia